Alyeska Investment Group
ORGO icon

Alyeska Investment Group’s Organogenesis Holdings ORGO Stock Holding History

Alyeska Investment Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,100,000
Closed -$16M – 471
2019
Q2 		$16M Hold
2,100,000
– – 0.21% 138
2019
Q1 		$15.8M Hold
2,100,000
– – 0.21% 136
2018
Q4 		$21.3M Hold
2,100,000
– – 0.31% 109
2018
Q3 		$21.3M Hold
2,100,000
– – 0.23% 121
2018
Q2 		$987K Hold
2,100,000
– – 0.01% 398
2018
Q1 		$65.5M Hold
2,100,000
– – 0.54% 65
2017
Q4 		$20.8M Hold
2,100,000
– – 0.17% 148
2017
Q3 		$21M Hold
2,100,000
– – 0.16% 176
2017
Q2 		$20.7M Buy
+2,100,000
New +$20.6M 0.17% 170

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Alyeska Investment Group's ORGO Position: Q4 2018 in Review

Alyeska Investment Group sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 2,100,000 shares — an estimated $21.2M sold.

Alyeska Investment Group first reported a position in ORGO in Q2 2017 and held it in 6 quarters. The position peaked at $21.3M in Q3 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

  • Alyeska Investment Group reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 2,100,000 Organogenesis Holdings shares in Q4 2018, an estimated $21.2M.
  • Alyeska Investment Group first reported a position in Organogenesis Holdings in Q2 2017 and held it in 6 quarters.
  • Alyeska Investment Group's Organogenesis Holdings position peaked at $21.3M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Alyeska Investment Group's 13F filing for Q4 2018, filed 14 Feb 2019.